Summary
The cytokine interleukin-1β may have an important role in the autoimmune mediated damage of pancreatic Beta cells in insulin-dependent diabetes mellitus. In the present study we have investigated the effects of an interleukin-1 receptor antagonist protein, a blocker of the type I interleukin-1 receptor, on the suppressive actions of recombinant interleukin-1β on insulin-producing cells. Brief exposure (1–2 h) of rat and mouse pancreatic islets to 10 ng/ml recombinant interleukin-1β induced an 70–80% inhibition of insulin response to glucose after 12 h. These effects were completely counteracted by co-incubation with 100 ng/ml interleukin-1 receptor antagonist protein. When rat islets were cultured for 48 h in the presence of recombinant interleukin-1β (5 ng/ml) higher concentrations of interleukin-1 receptor antagonist protein (5000 ng/ml) were required to protect Beta-cell function. Interleukin-1 receptor antagonist protein also counteracted the inhibitory effects of recombinant interleukin-1β on the growth of the rat insulinoma cell line RINm5F. These data suggest that interleukin-1 receptor antagonist protein can protect insulin-producing cells from the deleterious effects of recombinant interleukin-1β, and that these cells possess type I interleukin-1 receptors.
Article PDF
Avoid common mistakes on your manuscript.
References
Bendtzen K, Mandrup-Poulsen T, Nerup J, Dinarello CA, Svenson M, Nielsen JH (1986) Cytotoxicity of human pl 7 interleukin 1 for pancreatic islets of Langerhans. Science 232: 1545–1547
Eizirik DL, Welsh M, Strandell E, Welsh N, Sandler S (1990) Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein 70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 127: 2290–2297
Sandler S, Bendtzen K, Eizirik DL, Sjöholm Å, Welsh N (1989) Decreased cell replication and polyamine content in insulin-producing cells after exposure to human interleukin 1β. Immunol Lett 22: 267–272
Hammonds P, Beggs M, Beresford G, Espinal J, Clarke J, Mertz RJ (1990) Insulin-secreting β-cells possess specific receptors for interleukin-1β. FEBS Lett 261: 97–100
Hughes JH, Colca JR, Easom RA, Turk J, McDaniel ML (1990) Interleukin-1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 86: 856–863
Eizirik DL, Bendtzen K, Sandler S (1991) Short exposure of rat pancreatic islets to interleukin-1β induces a sustained but reversible impairment in β-cell function. This effect is influenced by protease activation, gene transcription and protein synthesis. Endocrinology 128: 1611–1616
Carter DB, Deibel MR, Dunn CJ et al. (1990) Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344: 633–638
Gershenwald JE, Fong Y, Fahey III TJ, Calvano SE, Chizzonite R, Killian PL, Lowry SF, Moldawer LL (1990) Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci (USA) 87: 4966–4970
Cominelli F, Nast CC, Clark BD, Schindler R, Llerena R, Eysselein VE, Thompson RC, Dinarello CA (1990) Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 86: 972–980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eizirik, D.L., Tracey, D.E., Bendtzen, K. et al. An interleukin-1 receptor antagonist protein protects insulin-producing Beta cells against suppressive effects of interleukin-1β. Diabetologia 34, 445–448 (1991). https://doi.org/10.1007/BF00403185
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00403185